Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • PharmaHopers launches...

    PharmaHopers launches derma franchise category for B2B businesses

    Farhat NasimWritten by Farhat Nasim Published On 2019-01-06T09:15:05+05:30  |  Updated On 6 Jan 2019 9:15 AM IST
    PharmaHopers launches derma franchise category for B2B businesses

    PharmaHopers has a number of dermatology companies listed which are involved in the marketing and manufacturing of derma products like Acne and rosacea drugs, dermatitis and seborrhea drugs, psoriasis drugs, fungal infection drugs and medicine for several other skin issues.


    Haryana: PharmaHopers, a B2B marketplace dedicated to pharmaceutical manufacturing and marketing companies, has forayed in the dermatology sector by introducing its Derma Franchise category. In India, prescription therapeutic and OTC dermatology market is witnessing rapid pace growth. This is due to the rise in skin problems, chronic and infectious skin disorders and constant development along with the commercialization of Derma products.


    “Dermatology is a highly specialised, niche segment in the global pharma industry. There is tremendous scope for developing creative pharma solutions incorporating new knowledge to make a significant market impact,” said Dr Rajesh Gokhale, Indian chemical biologist and the Director, Institute of Genomics and Integrative Biology, back in 2010.


    PharmaHopers, which was launched in 2016, has more than 300 pharma companies registered on it and now exploring the dermatology segment. Since skin is the largest organ of the human body and it is exposed, which makes it the first contact point for infection, microbes, and harms. Here, dermatology kicks in to prevent and cure skin issues.


    PharmaHopers has a number of dermatology companies listed which are involved in the marketing and manufacturing of derma products like Acne and rosacea drugs, dermatitis and seborrhea drugs, psoriasis drugs, fungal infection drugs and medicine for several other skin issues.


    PharmaHopers, based on the market research and study, claims to provide good business opportunities in the dermatology sector by bringing the buyers and sellers together under one roof. Demographics and challenges in dermatology sector stats in India for dermatology are near to unchanged but the concern of people towards their skin has increased.


    Psoriasis which is one of the common skin conditions has been more common among Indian men; prevalence varies from 0.44 to 2.8 per cent. According to the paediatric dermatologists, there are 30 per cent children suffering from Eczema and skin allergies. There was a time when treating these common skin issues were a huge challenge but now with the advancement of technology and the development of quality derma ranges things are different. Acne which is the most common problem among the youth has tolled up among boys and girls. Now, 50.6 per cent of boys and 38.13 per cent of girls who fall under the age group of 12-17 years suffer from acne in India. There are several other skin issues for which medicine are still under clinical trial.


    PharmaHopers is a B2B portal which includes the categories like pharma franchise and third party pharma manufacturing of dermatology products. The portal has all verified pharma companies registered on it which deal in the different healthcare segments.


    Also Read: Aurobindo to acquire Sandoz US dermatology, oral solids business for about Rs 6,470 crore CASH

    DemographicsdermaDerma FranchisedermatdermatitisDermatologyDr Rajesh GokhaleeczemaInstitute of Genomics and Integrative BiologyOTC dermatologypharmahopersPsoriasispsoriasis drugsRosacearosacea drugseborrhea drugs
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok